150 related articles for article (PubMed ID: 22001324)
1. Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors.
Kuo CC; Liu TW; Chen LT; Shiah HS; Wu CM; Cheng YT; Pan WY; Liu JF; Chen KL; Yang YN; Chen SN; Chang JY
Free Radic Biol Med; 2011 Dec; 51(12):2195-209. PubMed ID: 22001324
[TBL] [Abstract][Full Text] [Related]
2. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
Lösler S; Schlief S; Kneifel C; Thiel E; Schrezenmeier H; Rojewski MT
Ann Hematol; 2009 Nov; 88(11):1047-58. PubMed ID: 19301004
[TBL] [Abstract][Full Text] [Related]
3. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
Kanzawa T; Kondo Y; Ito H; Kondo S; Germano I
Cancer Res; 2003 May; 63(9):2103-8. PubMed ID: 12727826
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
Kanzawa T; Zhang L; Xiao L; Germano IM; Kondo Y; Kondo S
Oncogene; 2005 Feb; 24(6):980-91. PubMed ID: 15592527
[TBL] [Abstract][Full Text] [Related]
5. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
7. Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide.
Han YH; Kim SZ; Kim SH; Park WH
J Cell Biochem; 2008 Jun; 104(3):995-1009. PubMed ID: 18247324
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells.
Lin TH; Lu FJ; Yin YF; Tseng TH
Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345
[TBL] [Abstract][Full Text] [Related]
9. Carmustine induces ERK- and JNK-dependent cell death of neuronally-differentiated PC12 cells via generation of reactive oxygen species.
An JM; Kim SS; Rhie JH; Shin DM; Seo SR; Seo JT
Toxicol In Vitro; 2011 Oct; 25(7):1359-65. PubMed ID: 21600974
[TBL] [Abstract][Full Text] [Related]
10. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
Rice KP; Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
[TBL] [Abstract][Full Text] [Related]
13. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent.
Amadori S; Fenaux P; Ludwig H; O'dwyer M; Sanz M
Curr Med Res Opin; 2005 Mar; 21(3):403-11. PubMed ID: 15811209
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Zheng CY; Lam SK; Li YY; Ho JC
Int J Oncol; 2015 Mar; 46(3):1067-78. PubMed ID: 25572414
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment with arsenic trioxide and irradiation enhances apoptotic effects in U937 cells through increased mitotic arrest and ROS generation.
Ho SY; Chen WC; Chiu HW; Lai CS; Guo HR; Wang YJ
Chem Biol Interact; 2009 May; 179(2-3):304-13. PubMed ID: 19159621
[TBL] [Abstract][Full Text] [Related]
16. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide.
Zuo L; Li J; Yang Y; Wang X; Shen T; Xu CM; Zhang ZN
Ann Hematol; 2004 Dec; 83(12):751-8. PubMed ID: 15480664
[TBL] [Abstract][Full Text] [Related]
17. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
Duechler M; Stańczyk M; Czyz M; Stepnik M
Cancer Chemother Pharmacol; 2008 Apr; 61(5):727-37. PubMed ID: 17594095
[TBL] [Abstract][Full Text] [Related]
19. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Zhang RX; Dougherty DV; Rosenblum ML
Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]